34 studies found for:    DEMENTIA, LEWY BODY
Show Display Options
RSS Create an RSS feed from your search for:
DEMENTIA, LEWY BODY
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: E2020;   Drug: Placebo
2 Completed
Has Results
"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
Condition: Dementia With Lewy Bodies
Intervention: Drug: Armodafinil
3 Completed Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Parkinson's Disease Dementia;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
4 Completed Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
Conditions: Dementia Associated With Parkinson's Disease;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
5 Completed
Has Results
A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: E2020
6 Completed Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
7 Recruiting Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Intervention: Procedure: Electrical stimulation of the nucleus basalis of Meynert
8 Completed
Has Results
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: 3 mg Donepezil hydrochloride;   Drug: 5 mg Donepezil hydrochloride;   Drug: 10 mg Donepezil hydrochloride;   Drug: Placebo
9 Recruiting Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: Donepezil
10 Completed Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
Condition: Lewy Body Disease
Intervention: Drug: Galantamine
11 Unknown  Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
Conditions: Parkinsons Disease;   Lewy Bodies Disease
Intervention: Drug: Armodafinil
12 Recruiting Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
Conditions: Alzheimer's Disease;   Lewy Body's Dementia
Interventions: Other: Rey figure test;   Other: MRI
13 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
14 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
15 Recruiting Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
16 Recruiting A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
17 Recruiting Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
Condition: "Alzheimer's Disease" and "Lewy Body Disease"
Interventions: Other: MRI;   Procedure: lumbar puncture;   Behavioral: neuropsychological tests
18 Completed A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Conditions: Dementia With Lewy Bodies;   Alzheimer's Disease;   Parkinson's Disease
Interventions: Drug: 18F-AV-133;   Drug: 18F-AV-45
19 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
20 Unknown  Assessment of Social-emotional Functioning in Neurological Diseases
Conditions: Alzheimer Disease;   Stroke;   Parkinson's Disease;   Lewy Body Dementia;   Huntington Disease
Intervention: Behavioral: Computerized tests and Electrophysiological measurements

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years